PL BioScience has advanced an oral BPC-157 formulation (designated PL-10) to Phase II clinical trials for inflammatory bowel disease representing the most clinically advanced human development of oral BPC-157 to date.3 Human peer-reviewed results from these trials are pending, but the preclinical rationale is strong
GHK-Cu Copper Peptide GHK-Cu is a tripeptide that directly stimulates collagen synthesis, provides antioxidant protection, and regulates gene expression for tissue remodeling
Shelf life is 18 months from manufacture date when stored properly
Clinical trials confirmed no effect on serum IGF-1 levels, no negative effect on carbohydrate metabolism, and no anti-AOD-9604 antibodies detected in any participants
The InBody 580 provides a detailed analysis of your body composition, offering insights beyond what a traditional scale can provide
Reset Method For patients with degenerative arthritis, ligament or tendon tears, and painful, unstable joints